Company / Working Capital
Protagonist Therapeutics, Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$532.1M
FY2025
5-year range
$211.9M / $544.2M
FY2021-FY2025
Trend
-2.2%
vs FY2024
Sector context
#83 of 213
Health Care
What the data says
At $532M, Protagonist Therapeutics, Inc.'s working capital ranks #83 of 213 in the Health Care sector. Working Capital has fluctuated over the past 10 years, ranging from $77M in FY2016 to $544M in FY2024.
Based on SEC 10-K filings.
$532M in FY2025 with a 5-year CAGR of +14.1%.
Improved from $334M to $532M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +35.9%
- 5-Year CAGR
- +14.1%
- 10-Year CAGR
- -
Sector benchmark
#83 of 213 in Health CareTop 39% of 213This company $532.1M Sector average $934.6M
▼
-43.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +14.1%, indicating consistent growth.
- In FY2025, working capital decreased 2.2% year-over-year.
- Ranks #83 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.66 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $532.1M | -2.2% |
| FY2024 | $544.2M | +62.8% |
| FY2023 | $334.3M | +57.8% |
| FY2022 | $211.9M | -28.6% |
| FY2021 | $296.7M | +7.8% |
| FY2020 | $275.4M | +150.5% |
| FY2019 | $109.9M | -1.3% |
| FY2018 | $111.3M | +2.7% |
| FY2017 | $108.4M | +41.1% |
| FY2016 | $76.8M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026